Ho Chi Sing - 30 Dec 2024 SCHEDULE 13D/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares, $0.0001 par value (CASI)

Filing Manager
Ho Chi Sing
Reporting Manager
Quan Zhou
Security
CASI Pharmaceuticals, Inc. Ordinary Shares, $0.0001 par value
Symbol
CASI
Shares outstanding
15,509,969 shares
Disclosed Ownership
992,638 shares
Ownership
6.4%
Form type
SCHEDULE 13D/A
Filing time
03 Feb 2025, 20:17:59 UTC
Date of event
30 Dec 2024
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
IDG-Accel China Growth Fund III L.P. 5.9% 915,850 855,222 60,628 /s/ Chi Sing Ho on behalf of IDG-Accel China Growth Fund GP III Associates Ltd., ultimate General Partner of IDG-Accel China Growth Fund III L.P. Chi Sing Ho / Authorized Signatory 0001508829
IDG-Accel China III Investors L.P. 5.9% 915,850 60,628 855,222 /s/ Chi Sing Ho on behalf of IDG-Accel China Growth Fund GP III Associates Ltd., General Partner of IDG-Accel China III Investors L.P. Chi Sing Ho / Authorized Signatory 0001550193
IDG-Accel China Growth Fund III Associates L.P. 5.9% 915,850 855,222 60,628 /s/ Chi Sing Ho on behalf of IDG-Accel China Growth Fund GP III Associates Ltd., General Partner of IDG-Accel China Growth Fund III Associates L.P. Chi Sing Ho / Authorized Signatory 0001550192
IDG-Accel China Growth Fund GP III Associates Ltd. 5.9% 915,850 915,850 0 /s/ Chi Sing Ho Chi Sing Ho / Authorized Signatory 0001564281
Ho Chi Sing 5.9% 915,850 0 915,850 /s/ Ho Chi Sing Ho Chi Sing 0001545806
Quan Zhou 6.4% 992,638 76,788 915,850 /s/ Quan Zhou Quan Zhou 0001491503